GlassScriptPhysician profile
David Dzurick
NPI 1922621861
$4,329.49
in general payments reported to CMS, 2019-2025
14 companies · $84.13 in 2025
The $84.13 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $837 · 2022: $634 · 2023: $1,901 · 2024: $873 · 2025: $84.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,442 · Food and Beverage: $1,280 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,441.54 |
| Food and Beverage | $1,279.93 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,946.15 | 2023-2024 | Stratafix |
| Biohaven Pharmaceuticals, INC. | $460.81 | 2021 | |
| Janssen Pharmaceuticals, INC | $391.06 | 2022-2024 | Spravato |
| Abbvie INC. | $250.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.68 | 2023-2024 | Jardiance |
| Ethicon US, LLC | $205.70 | 2021-2025 | Echelon Flex, Stratafix |
| Glaxosmithkline, LLC. | $125.00 | 2024 | Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $124.88 | 2022 | |
| Amgen INC. | $123.99 | 2021 | |
| Edwards Lifesciences Corporation | $112.32 | 2022 | |
| Novo Nordisk INC | $107.53 | 2024 | |
| Genzyme Corporation | $107.46 | 2021 | |
| Stryker Corporation | $85.28 | 2021-2025 | Triathlon, Infinity Adaptis, Inbone |
| Hologic Sales and Service, LLC | $50.63 | 2024 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dzurick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.